SOME RELATED FACTORS WITH THE COMPLICATIONS OF ADRENALINEAL INFUSION CAUSED BY GLUCOCORTICOIDS IN GOUT PATIENTS AT HAI DUONG GENERAL HOSPITAL
Main Article Content
Abstract
Objective: To analyze some factors related actors to the complications of adrenal insufficiency caused by the use of glucocorticoids in gout patients. Method: Cross-sectional descriptive study design. Including 102 eligible patients. Convenient sampling method. Results: High-dose glucocorticoids were used most in the patient group, accounting for 46.1%. Using GCs with a daily dose of > 7.5 mg prednisolone, for a period of ≥ 1 month, causes adrenal insufficiency with more symptoms and is more likely to cause hyponatremia than using the drug with a daily dose of ≤ 7.5 mg, for a period of < 1 month. Using glucocorticoids systemically also causes adrenal insufficiency with more symptoms and is more likely to cause hyponatremia than using the topical route. Conclusion: Gout is a specialized disease, with many risk factors for adrenal insufficiency if Glucocorticoids are prescribed. Therefore, the disease must be well managed so that patients can live with the disease for a long time, reduce side effects of treatment drugs, minimize complications, and improve their quality of life
Article Details
Keywords
related factors, adrenal insufficiency, gout
References
2. Broersen LHA, Pereira AM, Jørgensen JOL, Dekkers OM (2015). Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. 2015; 100(6):2171-2180. doi:10.1210/jc.2015-1218.
3. Joseph RM, Hunter AL, Ray DW, Dixon WG (2016). Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review. Seminars in Arthritis and Rheumatism. 2016;46(1):133-141.
4. Janssens HJ, Lucassen PLBJ, Van de Laar FA, Janssen M, Van de Lisdonk EH (2008), Systemic steroids for acute gout, The Cochrane Collaboration.
5. D. Liu, A. Ahmet, L. Ward và cộng sự (2013). A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol, 9 (1), 30.
6. Moghadam-Kia S, Werth VP (2010). Prevention and treatment of systemic glucocorticoid side effects. International Journal of Dermatology. 2010;49(3):239-248.
7. Spasovski G, Vanholder R, Allolio B, et al (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology Dialysis Transplantation. 2014;29(suppl_2):i1-i39. doi:10.1093/ndt/gfu040.
8. Hoàng Anh Tài (2021), Nhận xét đặc điểm lâm sàng, cận lâm sàng và một số yếu tố liên quan của bệnh nhân suy thượng thận do dùng Glucocorticoids, Luận văn tốt nghiệp thạc sỹ y khoa, Đại học Y Hà Nội.
9. Vũ Thị Thục Trang. Đặc điểm lâm sàng, cận lâm sàng và đáp ứng điều trị của đợt cấp ở bệnh nhân suy thượng thận do thuốc. Tạp chí Y học Việt Nam Tập 483.